Only 28,442 monkeypox cases in U.S., 77,174 worldwide.
QUICK FACTS:
- The World Health Organization (WHO) on Monday said the monkeypox outbreak—the majority of cases occurring among men who have sex with men—still represents a global health emergency of the highest alert level, after holding an “Emergency Committee” meeting.
- The WHO is continuing to label the monkeypox outbreak a “Public Health Emergency of International Concern (PHEIC),” an official designation that cues a coordinated international response that “could unlock funding to collaborate on sharing vaccines and treatments,” Reuters reports.
- “The Committee held the consensus view that the event continues to meet the IHR criteria for a Public Health Emergency of International Concern (PHEIC) and highlights the primary reasons for ongoing concern,” an official WHO statement reads.
- “These include ongoing transmission in some regions, continuing preparedness and response inequity within and between WHO Member States, an emerging potential for greater health impact in vulnerable populations, continuing risk of stigma and discrimination, weak health systems in some developing countries leading to under-reporting, ongoing lack of equitable access to diagnostics, antiviral and vaccines, and research gaps needing to be addressed,” the WHO statement went on to say.
- There have been 28,442 confirmed monkeypox cases in the U.S. and 77,174 cases worldwide, according to the Centers for Disease Control and Prevention (CDC).
- The COVID-19 outbreak was similarly designated a Public Health Emergency of International Concern by WHO Director-General Tedros Adhanom Ghebreyesus on Jan 30, 2020, following the Emergency Committee’s recommendation.
AMERICAN FAITH’S LIST OF CONCERNS ABOUT THE MONKEYPOX VACCINE, IGNORED BY MAINSTREAM & ALTERNATIVE MEDIA:
- The FDA package insert for Bavarian Nordic’s monkeypox vaccine states that heart problems of “special interest” occur in 1 in 75 vaccine recipients who have not already been vaccinated against smallpox, but also in 1 in 48 vaccine recipients who have already been vaccinated against smallpox. The insert indicates Bavarian Nordic added ‘tromethamine,’ a drug given to treat heart attacks, to the vaccine.
- The CDC reported how one in four women (25%) who became pregnant after being injected with Bavarian Nordic’s monkeypox vaccine suffered a “spontaneous abortion.”
- The monkeypox vaccine insert also says the vaccine “has not been evaluated” for “[i]mpairment of male fertility.”
- It is not known whether Bavarian Nordic’s monkeypox vaccine is excreted in human breastmilk: “Data are not available to assess the effects of JYNNEOS in the breastfed infant or on milk production/excretion,” according to the FDA insert.
- The insert also warns that the monkeypox vaccine “has not been evaluated for carcinogenic or mutagenic potential,” meaning it is unknown whether the vaccine causes cancer or genetic mutations in humans.
- MIT reported earlier this month how Bavarian Nordic’s vice president of clinical strategy, Heinz Weidenthaler, admitted the effectiveness of the company’s monkeypox vaccine has not yet been tested: “[W]e’ve simply had no opportunity to test this in humans,” said Weidenthaler.
- There are no long-term studies evaluating how the monkeypox vaccine will interact with the COVID-19 vaccine, itself already linked to heart disease (here, here, here, here).
- The WHO has admitted that the monkeypox vaccine is “not 100% effective” against the virus.
BACKGROUND:
- In March 2021, a full 14 months before the global monkeypox outbreak, a Washington, D.C.-based think tank called The Nuclear Threat Initiative (NTI) conducted an “exercise scenario” that predicted “a deadly, global pandemic involving an unusual strain of monkeypox virus,” according to a paper published by the group, describing the scenario, American Faith reported in Aug 2022.
- “In March 2021, the Nuclear Threat Initiative (NTI) partnered with the Munich Security Conference (MSC) to conduct a tabletop exercise on reducing high-consequence biological threats,” the paper reads. “Conducted virtually, the exercise examined gaps in national and international biosecurity and pandemic preparedness architectures and explored opportunities to improve capabilities to prevent and respond to high-consequence biological events.”
- The paper then explained the scenario would involve an “unusual” monkeypox outbreak, just like the one that would occur in reality a little more than a year later: “The exercise scenario portrayed a deadly, global pandemic involving an unusual strain of monkeypox virus that emerged in the fictional nation of Brinia and spread globally over 18 months.”
- The paper even contains a timeline of events, including a prediction of when the monkeypox outbreak would occur, how many people would die, and when they would die.
- Astoundingly, the paper predicted the outbreak would occur on May 15, 2022, just seven days after the first, real monkeypox infection in the U.K. (May 8) and three days before the first infection in the U.S. (May 18).
- The last monkeypox outbreak occurred back in 2003, when 47 people in the U.S. were infected with the virus traced to a shipment of animals from Ghana. There was a smaller outbreak in Britain in 2018, according to CNN.
- The NTI paper went on to predict that the outbreak would be caused by a “terrorist attack” leading to billions of infections and hundreds of millions of deaths by December 1, 2023: “Ultimately, the exercise scenario revealed that the initial outbreak was caused by a terrorist attack using a pathogen engineered in a laboratory with inadequate biosafety and biosecurity provisions and weak oversight. By the end of the exercise, the fictional pandemic resulted in more than three billion cases and 270 million fatalities worldwide.”
- Again astonishingly, NTI also predicted the number of worldwide monkeypox infections to the week, forecasting that by June 5, 2022 there would be 1,421 cases. By June 14—just nine days after NTI’s prediction—POLITICO reported more than 1,600 confirmed cases across at least 39 countries.
- Looking forward, the NTI paper says that by January 10, 2023, there will be 70 million monkeypox cases and 27 million deaths and that by December 1, 2023, there will be 3.2 billion cases and 271 million deaths.
